Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer
Clinical trial NCT07059949 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07059949
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2027-01-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.